|View printer-friendly version|
|Mead Johnson Reports Strong Second Quarter and First Half Results; Second Quarter Constant Dollar Sales up 18 Percent; Raises Full-Year Guidance|
GLENVIEW, Ill., Jul 28, 2011 (BUSINESS WIRE) --
Mead Johnson Nutrition Company (NYSE: MJN) announced today its financial results for the second quarter ended June 30, 2011.
"We are very pleased with our strong sales and earnings performance in the second quarter," said Chief Executive Officer Stephen W. Golsby. "Our emerging markets business continued to deliver exceptional growth, led by China/Hong Kong and our markets in Latin America. It is clear that our investments in advertising and promotion, geographic expansion and product innovation are bearing fruit. We also saw significant sales growth in the U.S. driven by market share gains. We will face headwinds in the second half of the year from significantly higher commodity costs and more challenging comparisons with the prior year, but I'm pleased with the positive momentum in the business."
Second Quarter Results
Net sales for the quarter ended June 30, 2011, totaled $932.0 million, up 22 percent from $764.2 million a year ago. Sales benefited 17 percent from volume, 4 percent from foreign exchange and 1 percent from price. Earnings before interest and income taxes (EBIT) for the second quarter totaled $203.7 million, up 18 percent from $172.9 million a year earlier. The EBIT increase was primarily due to higher sales and improved gross margins, partially offset by increased demand-generation investments, stand-alone IT platform implementation costs and accruals for performance-based compensation.
Gross margin was up 120 basis points versus the second quarter of 2010 as productivity, geographic mix and higher volumes more than offset higher commodity costs. Operating expenses increased from higher sales force and distribution expenses, advertising and promotion investments, IT separation costs, performance-based compensation and shared service overlap costs. The effective tax rate for the quarter was 29.6 percent versus 24.1 percent a year ago and the increase was mainly attributable to changes in our geographic earnings mix along with the standard quarterly accruals necessary to true up our tax liability to the latest full-year projected tax rate. The 24.1 percent effective tax rate in the second quarter of 2010 was well below the full year actual rate of 27.8 percent.
Net earnings attributable to shareholders for the second quarter of 2011 totaled $132.1 million, or $0.64 per diluted share, compared with $121.4 million, or $0.59 per diluted share for the prior-year period.
On a non-GAAP basis, which excludes specified items, net earnings attributable to shareholders totaled $148.7 million, or $0.72 per diluted share, compared with $130.1 million, or $0.63 per diluted share, for the same quarter a year ago.
Second Quarter Segment Results
The Asia/Latin America segment had net sales of $611.6 million for the second quarter of 2011, up 30 percent from $471.7 million in 2010. Sales benefited 21 percent from volume, 6 percent from foreign exchange and 3 percent from price. Segment performance was driven by strong growth in China/Hong Kong and in most of the Latin America markets resulting both from market growth and market share strength. EBIT totaled $209.8 million, up 33 percent compared with $157.7 million for the year-ago second quarter. EBIT increased from strong sales and improved gross margins, partially offset by higher advertising and promotion investments, sales force expansion, performance-based compensation and new shared service costs.
The North America/Europe segment reported net sales of $320.4 million for the second quarter of 2011, up 10 percent from $292.5 million in 2010. Sales benefited 10 percent from volume and 1 percent from foreign exchange, along with a 1 percent decline in price. Strong sales performance was driven by market share gains in the U.S. from successful product launches in the prior year and the effect of a competitor's product recall late in 2010. The U.S. business grew despite the ongoing decline in births. EBIT totaled $86.4 million, up 10 percent compared with $78.2 million in the second quarter a year ago. EBIT increased from strong sales and improved gross margins partially offset by demand-generation investments, performance-based compensation and new shared service costs.
Corporate and Other expenses increased due to higher IT separation costs and foreign exchange impacts.
Net sales for the six months ended June 30, 2011, totaled $1,831.8 million, up 20 percent from $1,527.7 million a year ago. Sales benefited 14 percent from volume, 3 percent from price and 3 percent from foreign exchange. EBIT for the first half of 2011 totaled $426.3 million, up 15 percent from $370.8 million a year earlier. The EBIT increase was driven by higher sales and improved gross margins, partially offset by increased demand-generation investments, IT separation costs, performance-based compensation and shared service overlap costs.
Net earnings attributable to shareholders for the first half of 2011 totaled $278.2 million, or $1.35 per diluted share, compared with $247.0 million, or $1.20 per diluted share for the prior-year period.
On a non-GAAP basis, which excludes specified items, net earnings attributable to shareholders totaled $305.5 million, or $1.48 per diluted share, for the first half of 2011, compared with $263.9 million, or $1.28 per diluted share, for the same period a year ago.
Six-Month Segment Results
The Asia/Latin America segment had net sales of $1,188.5 million for the first half of 2011, up 28 percent from $927.7 million in 2010. Sales benefited 18 percent from volume, 5 percent from price and 5 percent from foreign exchange. The majority of the markets in the segment had double-digit constant-dollar sales growth driven by overall market growth and share gains from product and packaging innovation. China/Hong Kong posted the highest growth rate in the segment. EBIT for the segment totaled $426.6 million, up 32 percent compared with $324.0 million for the year-ago period. The EBIT increase was primarily related to sales growth and improved gross margin, partially offset by increased demand-generation investments, performance-based compensation and new shared service costs.
The North America/Europe segment reported net sales of $643.3 million for the first half of 2011, up 7 percent compared with $600.0 million in 2010. Sales benefited 7 percent from volume and 1 percent from foreign exchange, offset by a 1 percent decline in price. The segment sales were led by U.S. market share gains from product innovation launched in the prior year and the effect of a competitor's product recall late in 2010, partially offset by lower U.S. births. EBIT totaled $179.3 million, up 2 percent compared with $175.3 million in the same period a year ago. EBIT increased from sales growth and improved gross margins, partially offset by increased advertising and promotion investments, distribution and sales force expenses, higher performance-based compensation and new shared service costs.
Corporate and Other expenses increased due to higher IT separation costs and foreign exchange impacts.
Outlook for 2011
"For the full year, we anticipate higher sales and earnings growth than our previous guidance," Mr. Golsby said. "Based on our strong second quarter performance and positive outlook, annual net sales are estimated to grow by up to 14 percent on a constant dollar basis versus the prior year. With the commodity cost headwinds that we'll face in the second half of 2011, we expect annual gross margin to be around 63.2 percent of sales. We expect that operating costs will run about 39.7 percent of sales, including additional demand-generation investments to drive future sales growth, as well as higher operating expenses. We expect the effective tax rate will be in the range of 29.0 to 29.5 percent. As a result of all these factors, we are raising our full year non-GAAP earnings estimate to $2.70 to $2.75 per share."
Conference Call Scheduled
The company will host a conference call at 8:00 a.m. CDT today during which company executives will review second quarter financial results and respond to questions from analysts and investors. The call will be broadcast over the Internet at meadjohnson.com. To listen to the call, go to the Web site at least 15 minutes before the call and click on the Investors tab. Security analysts and investors wishing to participate by telephone should call 1-866-510-0707, pass code: Mead Johnson. Callers outside of North America should call +1-617-597-5376 to be connected. A replay of the conference call will be available through midnight EDT Thursday, Aug. 4, 2011, by calling 1-888-286-8010 or +1-617-801-6888, pass code: 51372616. The replay will also be available at meadjohnson.com.
Certain statements in this news release are forward looking as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are identified by words such as "expects," "intends" and "believes," involve certain risks, uncertainties and assumptions that may cause actual results to differ materially from expectations as of the date of this news release. These risks include, but are not limited to: (1) the ability to sustain brand strength, particularly the Enfa family of brands; (2) the effect on the company's reputation of real or perceived quality issues; (3) the adverse effect of commodity costs; (4) increased competition from branded, private label, store and economy-branded products; (5) the effect of an economic downturn on consumers' purchasing behavior and customers' ability to pay for product; (6) inventory reductions by customers; (7) the adverse effect of changes in foreign currency exchange rates; (8) the effect of changes in economic, political and social conditions in the markets where we operate; (9) legislative, regulatory or judicial action that may adversely affect the company's ability to advertise its products or maintain product margins; (10) the possibility of changes in the Women, Infant and Children (WIC) program, or increases in levels of participation in WIC; (11) business disruption due to a systems failure during the transition to a stand-alone platform; and (12) the ability to develop and market new, innovative products. For additional information on these and other factors, see the risk factors identified in the company's periodic reports, including the annual report on Form 10-K for 2010, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with, or furnished to, the Securities and Exchange Commission, available upon request or at meadjohnson.com. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
About Mead Johnson
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's "Enfa" family of brands, including Enfamil(R) infant formula, is the world's leading brand franchise in pediatric nutrition. For more information, go to meadjohnson.com.
Non-GAAP Financial Measures
This news release contains non-GAAP financial measures, including non-GAAP EBIT, earnings and earnings per share information. The items included in GAAP measures, but excluded for the purpose of determining non-GAAP EBIT, earnings and earnings per share, are IT separation and other costs (Specified Items). In addition, other items include the tax impact on Specified Items. Non-GAAP EBIT, earnings and earnings per share information adjusted for these items is an indication of the company's underlying operating results and intended to enhance an investor's overall understanding of the company's financial performance. In addition, this information is among the primary indicators the company uses as a basis for evaluating company performance, setting incentive compensation targets, and planning and forecasting of future periods. This information is not intended to be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. Tables that reconcile GAAP to non-GAAP disclosure follow:
SOURCE: Mead Johnson Nutrition Company
Mead Johnson Nutrition Company